GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations
{{output}}
Background: Despite the rapid increase in glucagon-like peptide-1 receptor agonist (GLP-1) use for management of weight among adolescents (ages 12-18 years), there is limited guidance on associated behavioral health considerations. Adolescents on GLP-1 therapy... ...
